(2021). Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs.
Chicago Style (17th ed.) CitationImpact of Detecting Plasma EGFR Mutations with Ultrasensitive Liquid Biopsy in Outcomes of NSCLC Patients Treated with First- or Second-generation EGFR-TKIs. 2021.
MLA (8th ed.) CitationImpact of Detecting Plasma EGFR Mutations with Ultrasensitive Liquid Biopsy in Outcomes of NSCLC Patients Treated with First- or Second-generation EGFR-TKIs. 2021.
Warning: These citations may not always be 100% accurate.